Oscar Health, Inc. current report, 09 January 2023

Business Context and Reporting Period

This Form 8-K was filed by Oscar Health, Inc. on January 9, 2023. The report announces the company's participation in the 41st Annual J.P. Morgan Healthcare Conference on January 11, 2023, where management will reaffirm previously issued guidance and provide updates on 2023 open enrollment.

Key Financial Metrics

The filing does not contain specific historical financial data such as revenue, profit, cash flow, margins, debt, or liquidity figures. It references preliminary 2022 financial results that are estimates and subject to change upon completion of year-end accounting procedures.

Material Changes

No material changes to financial results or operations are reported in this document. The filing serves to confirm that the company will reaffirm the updated full-year 2022 guidance originally provided in the November 8, 2022, third-quarter press release.

Guidance, Outlook, and Risks

  • 2022 Outlook: The company will reaffirm its updated full-year 2022 guidance at the J.P. Morgan Healthcare Conference.
  • 2023 Targets: Management will reaffirm its 2023 profitability target for its InsuranceCo segment.
  • Membership Update: An interim update on membership from the 2023 open enrollment period will be provided.
  • Forward-Looking Statements: The filing includes standard cautionary notes that forward-looking statements are not guarantees and are subject to risks and uncertainties detailed in the company's Form 10-Q for the period ended September 30, 2022.
  • Financial Disclosure Advisory: Preliminary 2022 results discussed at the conference are estimates. Actual results in the upcoming Form 10-K may differ due to final accounting adjustments and audit procedures.

Investor Verification Checklist

  • Verify the specific numerical values of the reaffirmed 2022 guidance and 2023 profitability targets during the January 11, 2023, J.P. Morgan Healthcare Conference presentation.
  • Review the interim 2023 open enrollment membership figures to be disclosed at the conference.
  • Monitor the upcoming Form 10-K for the year ended December 31, 2022, to confirm if actual audited results differ materially from the preliminary estimates mentioned in this filing.
  • Consult the "Risk Factors" section of the most recent Form 10-Q for details on uncertainties affecting forward-looking statements.